☆ 4.6 Letter

The Impact of COVID-19 on Individuals With Intellectual and Developmental Disabilities: Clinical and Scientific Priorities

AMERICAN JOURNAL OF PSYCHIATRY (2020)

Get Full Text
Add to Collection

Journal

AMERICAN JOURNAL OF PSYCHIATRY
Volume 177, Issue 11, Pages 1091-1093

Publisher

AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ajp.2020.20060780

Keywords

-

Categories

Psychiatry

Funding

  1. Astellas
  2. Biogen
  3. Boston Children's Hospital Intellectual and Developmental Disabilities Research Center
  4. Bridgebio
  5. Developmental Synaptopathies Consortium
  6. Ipsen
  7. LAM Therapeutics
  8. Novartis
  9. Pfizer
  10. Quadrant Biosciences
  11. Roche

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.